WASHINGTON— It flew through the Republican-run House in 2012, and a year later 79 of the Democratic-led Senate's 100 members embraced it. With Republicans now controlling both chambers of Congress, the chances for repealing the 2.3 percent tax on medical devices are better than ever. Created under Obama's expansion of health care coverage, the tax will raise...» Read More
WASHINGTON, Aug 14- A senior U.S. senator said on Thursday he has written to Hospira Inc and urged the drug and medical device maker not to move its tax domicile abroad to save on U.S. taxes.
Shares of Malaysia's latex glove makers have had a tough year so far, but some analysts expect panic over Africa's Ebola outbreak may spur gains.
BOSTON, Aug 13- Harvard Management Co, which oversees the Ivy League school's $32.7 billion endowment, took a new position in surgical device maker Covidien Plc during the second quarter before news of a planned takeover helped push the stock price higher, a regulatory filing shows.
SAN FRANCISCO, Aug 12- Apple Inc has been discussing how its "HealthKit" service will work with health providers at Mount Sinai, the Cleveland Clinic and Johns Hopkins as well as with Allscripts, a competitor to electronic health records provider Epic Systems, people familiar with the discussions said.
U.S. biotech firm Celladon hopes that its Mydicar treatment can help patients like Lee Adams who have advanced heart failure and rely on so called Left Ventricular Assist Devices to keep them alive until a donor heart becomes available.
SAN FRANCISCO, Aug 6- Practice Fusion, provider of a free electronic health record service for doctors, bought app developer Ringadoc on Wednesday as it moves into a new market: telemedicine. Research firm IHS forecast that the U.S. market will grow to $1.9 billion in 2018, from $240 million in 2013..
Lawrence Livermore is reaching out to private industry amid a race for talent and ideas to solve pressing issues including national security.
CRE, one of the worst of the superbugs, is spreading in some hospitals, and there's worry that cases are under-reported.
As AstraZeneca's shares slid following its rejection of Pfizer's new bid, the company's chairman said he was "reasonably confident" it was the right decision.
Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.
As healthcare reform begins to take shape, venture capitalists see emerging opportunities in digital health start-ups.
P&G is bringing the dentist into your bathroom a smartphone-connected toothbrush, a device that gives personalized advice to help people improve their brushing.
The White House is coming under pressure from some of its closest allies to name a CEO to run its health insurance marketplace.
Activist investor Carl Icahn reported a 12.63 stake in medical device maker Hologic, prompting the company to seek protection from a hostile takeover
An entrepreneur has attracted investments from four billionaires: Sam Zell, Herb Simon, David Bonderman and "one family you've never heard of."
Johnson & Johnson and its subsidiaries were accused of promoting powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients.
Pharmaceutical and biotech stocks have outperformed markets this year, and with J&J's second-quarter earnings beat, investors may hope earnings will push stocks even higher.
Americans accustomed to immediate access to the newest technology may be shocked to find that is not the case when it comes to devices that treat ailing hearts.
Keith Smith, Co-founder, Managing Partner at the Surgery Center of Oklahoma says that all funds are channeled to patient care, helping his team deliver quality healthcare and low costs.
Most robotic surgery takes place without a hitch, but a growing number of complaints and lawsuits allege complications and even deaths from Intuitive Surgical's da Vinci device.